Literature DB >> 21862438

Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities.

Roberta Biundo1, Patrizia Formento-Dojot, Silvia Facchini, Annamaria Vallelunga, Luca Ghezzo, Luciano Foscolo, Francesca Meneghello, Angelo Antonini.   

Abstract

Cognitive and behavioral abnormalities are frequent in Parkinson's disease (PD) but their anatomical correlates are still uncertain. We assessed a cohort of 59 PD patients with and without impulse control disorders (PD-ICDs and PD-CNTR) with magnetic resonance imaging and a comprehensive neuropsychological battery. Thirty-five PD patients presented ICDs according to DSM-IV criteria and Minnesota Impulsive Disorders Interview. We found areas of significant brain atrophy in the middle and superior frontal gyrus in the whole cohort of 59 PD patients vs. healthy controls but there were no morphometric changes in PD-ICDs vs. PD-CNTR. This was consistent with cognitive findings of relatively preserved function in PD-ICDs with the exception for slower performance in the Trail Making Test B-A suggesting difficulties to maintain goal-directed tasks and suppress irrelevant responses. Voxel Based Morphometric regression analysis (VBM) carried out using TMTB-A as independent factor showed a negative gray matter correlation between high TMTB-A scores and left middle frontal cortex, right posterior cingulate area, anterior cingulate and supplementary motor area bilaterally. Our results suggest that PD is characterized by an overall loss of gray matter in pre-frontal regions. However, the contribution of these changes to the development of ICDs is marginal.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21862438     DOI: 10.1016/j.jns.2011.08.001

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  32 in total

1.  Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease.

Authors:  F Imperiale; F Agosta; E Canu; V Markovic; A Inuggi; M Jecmenica-Lukic; A Tomic; M Copetti; S Basaia; V S Kostic; M Filippi
Journal:  Mol Psychiatry       Date:  2017-03-07       Impact factor: 15.992

Review 2.  Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

3.  Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging.

Authors:  Koji Kamagata; Andrew Zalesky; Taku Hatano; Ryo Ueda; Maria Angelique Di Biase; Ayami Okuzumi; Keigo Shimoji; Masaaki Hori; Karen Caeyenberghs; Christos Pantelis; Nobutaka Hattori; Shigeki Aoki
Journal:  Hum Brain Mapp       Date:  2017-05-04       Impact factor: 5.038

4.  Combining Diffusion Tensor Imaging and Susceptibility Weighted Imaging on the Substantia Nigra of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP)-induced Rhesus Monkey Model of Parkinson's Disease.

Authors:  Q Zhang; L Li; B Miao; H Niu
Journal:  West Indian Med J       Date:  2016-04-18       Impact factor: 0.171

5.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

Review 6.  The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

7.  Impulse control disorders in Parkinson's disease: background and update on prevention and management.

Authors:  Robert F Leeman; Benjamin E Billingsley; Marc N Potenza
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

Review 8.  A review of the use of magnetic resonance imaging in Parkinson's disease.

Authors:  Nadya Pyatigorskaya; Cécile Gallea; Daniel Garcia-Lorenzo; Marie Vidailhet; Stéphane Lehericy
Journal:  Ther Adv Neurol Disord       Date:  2014-07       Impact factor: 6.570

9.  Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease.

Authors:  J Vincent Filoteo; Jason D Reed; Irene Litvan; Deborah L Harrington
Journal:  Mov Disord       Date:  2013-09-03       Impact factor: 10.338

10.  Cognitive and MRI correlates of orthostatic hypotension in Parkinson's disease.

Authors:  Manuela Pilleri; Silvia Facchini; Elisabetta Gasparoli; Roberta Biundo; Laura Bernardi; Mauro Marchetti; Patrizia Formento; Angelo Antonini
Journal:  J Neurol       Date:  2012-08-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.